Characterization of the bacterial microbiome in first-pass meconium using propidium monoazide (PMA) to exclude

L F Stinson1, J A Keelan1, M S Payne1

  • 1Division of Obstetrics and Gynaecology, Faculty of Health & Medical Sciences, The University of Western Australia, Crawley, WA, Australia.

Insights

The fetal gut microbiome is seeded with intact bacterial cells before birth. This study used propidium monoazide (PMA) with 16S rRNA sequencing to differentiate live bacteria from DNA in meconium samples.

Area of Science:

  • Microbiology
  • Genomics
  • Fetal Development

Background:

  • Studies suggest the human gut microbiome is established before birth, with bacterial DNA detected in meconium.
  • Previous research could not distinguish between DNA from live, dead, or cell-free bacteria in fetal samples.

Purpose of the Study:

  • To investigate the presence of intact bacterial cells in the fetal gut.
  • To differentiate between viable and non-viable bacterial DNA in first-pass meconium samples.

Main Methods:

  • Utilized propidium monoazide (PMA) treatment combined with 16S rRNA gene sequencing.
  • Analyzed DNA from five first-pass meconium samples, with and without PMA treatment.
  • Compared bacterial DNA yields and operational taxonomic units (OTUs) between treated and untreated samples.

Main Results:

  • All meconium samples contained detectable bacterial DNA, with PMA reducing DNA yield by ~20%.
  • PMA treatment did not significantly alter the number of observed OTUs but did change taxonomic composition.
  • Approximately one-quarter of OTUs in untreated samples appeared to originate from cell-free or nonviable DNA.

Conclusions:

  • The fetal gut is indeed colonized by intact bacterial cells prior to birth.
  • This finding highlights the importance of excluding nonviable bacteria in low-biomass samples like meconium.
  • The presence of live bacteria during gestation may significantly influence fetal development.

Related Concept Videos

Bacterial Transformation01:33

Bacterial Transformation

In 1928, bacteriologist Frederick Griffith worked on a vaccine for pneumonia, which is caused by Streptococcus pneumoniae bacteria. Griffith studied two pneumonia strains in mice: one pathogenic and one non-pathogenic. Only the pathogenic strain killed host mice.
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
59.9K
Bacterial Signaling01:30

Bacterial Signaling

Bacterial signaling can occur within bacteria (intracellular) or between bacteria (intercellular). At times, a group of bacteria behaves like a community. To achieve this, they engage in quorum sensing, the perception of higher cell density that causes changes in gene expression. Quorum sensing involves both extracellular and intracellular signaling. The signaling cascade starts with a molecule called an autoinducer (AI). Individual bacteria produce AIs that move out of the bacterial cell...
40.6K
Bacterial RNA Polymerase00:43

Bacterial RNA Polymerase

Unlike eukaryotes, bacteria use a single RNA Polymerase (RNAP) to transcribe all genes. The different subunits of bacterial RNAPhave distinct functions. The multisubunit structure of the bacterial RNAP helps the enzyme to maintain catalytic function, facilitate assembly, interact with DNA and RNA, and self-regulate its activity.
In most genes, the transcription site is a single base present upstream of the coding sequence. Though RNAP is a catalytically efficient enzyme, it does not recognize...
32.7K
Bacterial Transcription01:53

Bacterial Transcription

RNA polymerase (RNAP) carries out DNA-dependent RNA synthesis in both bacteria and eukaryotes. Bacteria do not have a membrane-bound nucleus. So, transcription and translation occur simultaneously, on the same DNA template.
Transcription can be divided into three main stages, each involving distinct DNA sequences to guide the polymerase. These are:
36.5K
First Pass Effect01:12

First Pass Effect

Presystemic elimination, or the first-pass effect, is the metabolism of drugs that reduces their effective concentration at the site of action. Apart from the first-pass effect, the systemic bioavailability of the drug is also reduced by other factors, including incomplete absorption or chemical degradation of drugs.
Depending on the route of administration, drugs can be metabolized in the liver, intestine, lungs, and vasculature. Orally administered drugs are first absorbed through the...
9.3K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
2.8K